Report overview
The global AI In Oncology market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The application of AI in cancer practice includes providing clinical decision support for cancer diagnosis and screening, processing medical data for cancer detection or characterization of patient prognosis, and optimizing care delivery and clinical operations by increasing system capacity and allocating resources.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate �9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.131%, including software, hardware and services.
We have surveyed the AI In Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for AI In Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI In Oncology. This report contains market size and forecasts of AI In Oncology in global, including the following market information:
Global AI In Oncology market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five AI In Oncology companies in 2024 (%)
Total Market by Segment:
Global AI In Oncology market, by Type, 2020-2025, 2026-2032 ($ millions)
Global AI In Oncology market segment percentages, by Type, 2024 (%)
Software Solutions
Hardware
Services
Global AI In Oncology market, by Application, 2020-2025, 2026-2032 ($ millions)
Global AI In Oncology market segment percentages, by Application, 2024 (%)
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
Global AI In Oncology market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global AI In Oncology market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies AI In Oncology revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies AI In Oncology revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Azra AI
IBM
Siemens Healthineers
Intel
GE Healthcare
NVIDIA
Digital Diagnostics Inc.
Concert.AI
Median Technologies
Path AI
Outline of Major Chapters:
Chapter 1: Introduces the definition of AI In Oncology, market overview.
Chapter 2: Global AI In Oncology market size in revenue.
Chapter 3: Detailed analysis of AI In Oncology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of AI In Oncology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
